Mitotic bypass and endocycling promote cancer cell survival after genotoxic chemotherapy
Truskowski, K.; Rolle, L.; Butler, G.; Yang, M. E.; Pienta, K. J.; Amend, S. R.
Show abstract
Genotoxic chemotherapies are central components of the treatment regimen for most cancers but are rarely curative. Drug-tolerant persister cells (DTPs) evade cell death during these treatments by accessing transient adaptive states and can contribute to cancer progression after treatment. Here, we demonstrate that cancer cells can survive genotoxic chemotherapy-induced stress by accessing a DTP state wherein stress-induced bypass of mitosis precipitates continued endocycling which promotes survival by allowing cells to evade mitotic catastrophe and cell death. Mechanistic studies indicate that persistent DNA damage signaling in endocycling persister cells triggers sustained p53-independent CDK1 inhibition by WEE1 and Myt1. Continued survival in endocycling persisters is dependent on activation of this G2 checkpoint, and disrupting WEE1 or Myt1 activity using clinical-stage small molecule inhibitors is sufficient to drive CDK1 reactivation, forcing mitotic entry, catastrophe, and cell death. Our results define endocycling DTPs as targetable mediators of cancer cell persistence after genotoxic therapy.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- An Aurora kinase A-BOD1L1-PP2A B56 Axis promotes chromosome segregation fidelity 96%
- Excessive E2F transcription in single cancer cells precludes transient cell cycle exit after DNA damage. 96%
- BRD4 Prevents R-Loop Formation and Transcription-Replication Conflicts by Ensuring Efficient Transcription Elongation 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.